TRANSURETHRAL  ||| S:0 E:14 ||| NNP
URETEROLITHOTRIPSY  ||| S:14 E:33 ||| NNP
FOR  ||| S:33 E:37 ||| IN
UPPER  ||| S:37 E:43 ||| NNP
URINARY  ||| S:43 E:51 ||| NNP
TRACT  ||| S:51 E:57 ||| NNP
STONE  ||| S:57 E:63 ||| NNP
IN  ||| S:63 E:66 ||| IN
SMALL  ||| S:66 E:72 ||| NNP
CHILDREN  ||| S:72 E:81 ||| NNP
WEIGHNING  ||| S:81 E:91 ||| NNP
AROUND  ||| S:91 E:98 ||| NNP
10KG  ||| S:98 E:103 ||| NNP
Management  ||| S:103 E:114 ||| NNP
strategy  ||| S:114 E:123 ||| NN
for  ||| S:123 E:127 ||| IN
upper  ||| S:127 E:133 ||| JJ
urinary  ||| S:133 E:141 ||| JJ
tract  ||| S:141 E:147 ||| NN
calculi  ||| S:147 E:155 ||| NN
in  ||| S:155 E:158 ||| IN
small  ||| S:158 E:164 ||| JJ
children  ||| S:164 E:173 ||| NNS
is  ||| S:173 E:176 ||| VBZ
still  ||| S:176 E:182 ||| RB
a  ||| S:182 E:184 ||| DT
matter  ||| S:184 E:191 ||| NN
controversial ||| S:191 E:204 ||| JJ
.  ||| S:204 E:206 ||| .
We  ||| S:206 E:209 ||| PRP
report  ||| S:209 E:216 ||| VBP
successful  ||| S:216 E:227 ||| JJ
management  ||| S:227 E:238 ||| NN
of  ||| S:238 E:241 ||| IN
ureteral  ||| S:241 E:250 ||| JJ
stone  ||| S:250 E:256 ||| NN
with  ||| S:256 E:261 ||| IN
transurethral  ||| S:261 E:275 ||| JJ
ureterolithotripsy  ||| S:275 E:294 ||| NNS
( ||| S:294 E:295 ||| -LRB-
TUL ||| S:295 E:298 ||| NNP
)  ||| S:298 E:300 ||| -RRB-
in  ||| S:300 E:303 ||| IN
2  ||| S:303 E:305 ||| CD
boys  ||| S:305 E:310 ||| NNS
weighing  ||| S:310 E:319 ||| VBG
around  ||| S:319 E:326 ||| IN
10  ||| S:326 E:329 ||| CD
kg ||| S:329 E:331 ||| NNS
.  ||| S:331 E:333 ||| .
Case  ||| S:333 E:338 ||| NN
1 ||| S:338 E:339 ||| CD
:  ||| S:339 E:341 ||| :
A  ||| S:341 E:343 ||| DT
2-year-old  ||| S:343 E:354 ||| JJ
boy  ||| S:354 E:358 ||| NN
( ||| S:358 E:359 ||| -LRB-
78  ||| S:359 E:362 ||| CD
cm  ||| S:362 E:365 ||| NN
in  ||| S:365 E:368 ||| IN
height ||| S:368 E:374 ||| NN
,  ||| S:374 E:376 ||| ,
9.6  ||| S:376 E:380 ||| CD
kg  ||| S:380 E:383 ||| NN
in  ||| S:383 E:386 ||| IN
weight ||| S:386 E:392 ||| NN
) ||| S:392 E:393 ||| -RRB-
,  ||| S:393 E:395 ||| ,
who  ||| S:395 E:399 ||| WP
received  ||| S:399 E:408 ||| VBD
hydrocortisone  ||| S:408 E:423 ||| JJ
and  ||| S:423 E:427 ||| CC
fludrocortisone  ||| S:427 E:443 ||| NN
for  ||| S:443 E:447 ||| IN
the  ||| S:447 E:451 ||| DT
treatment  ||| S:451 E:461 ||| NN
of  ||| S:461 E:464 ||| IN
21-hydroxylase  ||| S:464 E:479 ||| CD
deficiency ||| S:479 E:489 ||| NN
,  ||| S:489 E:491 ||| ,
was  ||| S:491 E:495 ||| VBD
referred  ||| S:495 E:504 ||| VBN
to  ||| S:504 E:507 ||| TO
our  ||| S:507 E:511 ||| PRP$
hospital  ||| S:511 E:520 ||| NN
with  ||| S:520 E:525 ||| IN
a  ||| S:525 E:527 ||| DT
right  ||| S:527 E:533 ||| JJ
9-mm  ||| S:533 E:538 ||| NN
lower  ||| S:538 E:544 ||| RBR
ureteral  ||| S:544 E:553 ||| JJ
stone ||| S:553 E:558 ||| NN
.  ||| S:558 E:560 ||| .
For  ||| S:560 E:564 ||| IN
TUL ||| S:564 E:567 ||| NNP
,  ||| S:567 E:569 ||| ,
a  ||| S:569 E:571 ||| DT
7.5  ||| S:571 E:575 ||| CD
Fr  ||| S:575 E:578 ||| JJ
rigid  ||| S:578 E:584 ||| JJ
cystoscope  ||| S:584 E:595 ||| NN
was  ||| S:595 E:599 ||| VBD
introduced  ||| S:599 E:610 ||| VBN
into  ||| S:610 E:615 ||| IN
the  ||| S:615 E:619 ||| DT
ureter  ||| S:619 E:626 ||| NN
directly  ||| S:626 E:635 ||| RB
after  ||| S:635 E:641 ||| IN
dilation  ||| S:641 E:650 ||| NN
of  ||| S:650 E:653 ||| IN
the  ||| S:653 E:657 ||| DT
ureteral  ||| S:657 E:666 ||| JJ
orifice ||| S:666 E:673 ||| NN
.  ||| S:673 E:675 ||| .
By  ||| S:675 E:678 ||| IN
using  ||| S:678 E:684 ||| VBG
Holmium ||| S:684 E:691 ||| NNP
: ||| S:691 E:692 ||| :
YAG  ||| S:692 E:696 ||| NNP
laser  ||| S:696 E:702 ||| NN
for  ||| S:702 E:706 ||| IN
lithotripsy ||| S:706 E:717 ||| NN
,  ||| S:717 E:719 ||| ,
complete  ||| S:719 E:728 ||| JJ
stone  ||| S:728 E:734 ||| NN
evacuation  ||| S:734 E:745 ||| NN
was  ||| S:745 E:749 ||| VBD
achieved ||| S:749 E:757 ||| VBN
.  ||| S:757 E:759 ||| .
Stone  ||| S:759 E:765 ||| NNP
analysis  ||| S:765 E:774 ||| NN
showed  ||| S:774 E:781 ||| VBD
the  ||| S:781 E:785 ||| DT
composition  ||| S:785 E:797 ||| NN
of  ||| S:797 E:800 ||| IN
calcium  ||| S:800 E:808 ||| JJ
phosphate  ||| S:808 E:818 ||| NN
and  ||| S:818 E:822 ||| CC
calcium  ||| S:822 E:830 ||| JJ
oxalate ||| S:830 E:837 ||| NN
.  ||| S:837 E:839 ||| .
Case  ||| S:839 E:844 ||| NN
2 ||| S:844 E:845 ||| CD
:  ||| S:845 E:847 ||| :
A  ||| S:847 E:849 ||| DT
1-year-old  ||| S:849 E:860 ||| JJ
boy  ||| S:860 E:864 ||| NN
( ||| S:864 E:865 ||| -LRB-
80  ||| S:865 E:868 ||| CD
cm  ||| S:868 E:871 ||| NN
in  ||| S:871 E:874 ||| IN
height ||| S:874 E:880 ||| NN
,  ||| S:880 E:882 ||| ,
10.5  ||| S:882 E:887 ||| CD
kg  ||| S:887 E:890 ||| NN
in  ||| S:890 E:893 ||| IN
weight ||| S:893 E:899 ||| NN
)  ||| S:899 E:901 ||| -RRB-
with  ||| S:901 E:906 ||| IN
neurofibromatosis  ||| S:906 E:924 ||| JJ
type  ||| S:924 E:929 ||| NN
1  ||| S:929 E:931 ||| CD
was  ||| S:931 E:935 ||| VBD
referred  ||| S:935 E:944 ||| VBN
to  ||| S:944 E:947 ||| TO
our  ||| S:947 E:951 ||| PRP$
hospital  ||| S:951 E:960 ||| NN
with  ||| S:960 E:965 ||| IN
a  ||| S:965 E:967 ||| DT
left  ||| S:967 E:972 ||| JJ
7.5-mm  ||| S:972 E:979 ||| CD
ureteral  ||| S:979 E:988 ||| JJ
stone  ||| S:988 E:994 ||| NN
at  ||| S:994 E:997 ||| IN
the  ||| S:997 E:1001 ||| DT
ureteropelvic  ||| S:1001 E:1015 ||| JJ
junction ||| S:1015 E:1023 ||| NN
.  ||| S:1023 E:1025 ||| .
TUL  ||| S:1025 E:1029 ||| NNP
was  ||| S:1029 E:1033 ||| VBD
performed  ||| S:1033 E:1043 ||| VBN
using  ||| S:1043 E:1049 ||| VBG
a  ||| S:1049 E:1051 ||| DT
4.5  ||| S:1051 E:1055 ||| CD
F  ||| S:1055 E:1057 ||| NN
rigid  ||| S:1057 E:1063 ||| JJ
ureteroscope  ||| S:1063 E:1076 ||| NN
and  ||| S:1076 E:1080 ||| CC
Holmium ||| S:1080 E:1087 ||| NNP
: ||| S:1087 E:1088 ||| :
YAG  ||| S:1088 E:1092 ||| NNP
laser ||| S:1092 E:1097 ||| NN
.  ||| S:1097 E:1099 ||| .
No  ||| S:1099 E:1102 ||| DT
residual  ||| S:1102 E:1111 ||| JJ
stone  ||| S:1111 E:1117 ||| NN
was  ||| S:1117 E:1121 ||| VBD
identified ||| S:1121 E:1131 ||| VBN
.  ||| S:1131 E:1133 ||| .
Stone  ||| S:1133 E:1139 ||| NNP
analysis  ||| S:1139 E:1148 ||| NN
showed  ||| S:1148 E:1155 ||| VBD
the  ||| S:1155 E:1159 ||| DT
composition  ||| S:1159 E:1171 ||| NN
of  ||| S:1171 E:1174 ||| IN
calcium  ||| S:1174 E:1182 ||| JJ
oxalate ||| S:1182 E:1189 ||| NN
.  ||| S:1189 E:1191 ||| .
TUL  ||| S:1191 E:1195 ||| NNP
is  ||| S:1195 E:1198 ||| VBZ
a  ||| S:1198 E:1200 ||| DT
safe  ||| S:1200 E:1205 ||| JJ
and  ||| S:1205 E:1209 ||| CC
feasible  ||| S:1209 E:1218 ||| JJ
option  ||| S:1218 E:1225 ||| NN
for  ||| S:1225 E:1229 ||| IN
small  ||| S:1229 E:1235 ||| JJ
children ||| S:1235 E:1243 ||| NNS
,  ||| S:1243 E:1245 ||| ,
even  ||| S:1245 E:1250 ||| RB
in  ||| S:1250 E:1253 ||| IN
boys  ||| S:1253 E:1258 ||| NNS
weighing  ||| S:1258 E:1267 ||| VBG
approximately  ||| S:1267 E:1281 ||| RB
10  ||| S:1281 E:1284 ||| CD
kg ||| S:1284 E:1286 ||| NNS
.  ||| S:1286 E:1288 ||| .
